Article

New Generic Drugs Emerge for Migraines, Cardiovascular Conditions

Six new generic drugs for various cardiovascular-related conditions, brain cancer, and migraines expected to result in significant savings.

Last week, ACETO Corporation announced its subsidiary Rising Pharmaceuticals launched 6 new generic drugs.

The 6 newly-marketed drugs were found to have combined sales of $580 million from May 2016 to May 2017, according to a press release. These new generics may result in significant savings for patients and the healthcare system.

The 6 new generics include:

  • Ramipril capsules in 25-mg, 2.5-mg, 5-mg, and 10-mg doses. This drug is an approved generic for Altace manufactured by Pfizer. The drug is indicated to treat patients with hypertension.
  • Losartan potassium tablets in 25-mg and 50-mg capsules, which is an approved generic for Cozaar manufactured by Merck. This drug is also indicated for the treatment of hypertension, according to the release.
  • Losartan potassium and hydrochlorothiazide Tablets in 50-12.5-mg, 100-12.5-mg, and 100-25-mg doses. This combination therapy is an FDA-approved generic version of Hyzaar, manufactured by Merck. This drug is indicated to treat hypertension.
  • Pravastatin tablets in 10-mg, 20-mg, 40-mg, and 80-mg doses. This drug is an approved generic of Pravachol, which is manufactured by Bristol-Myers Squibb. Pravastatin is indicated to lower high cholesterol and triglyceride levels in conjunction with exercise and diet that restricts saturated fats and cholesterol, according to the release.
  • Temozolomide capsules in 5-mg, 20-mg, 100-mg, 140-mg, 180-mg, and 200-mg doses, which is an approved generic of Temodar manufactured by Merck. This drug is indicated to treat adult patients with newly diagnosed glioblastoma multiforme, according to the release. A generic cancer drug has the potential to improve access to treatment and reduce costs for patients.
  • Zolmitriptan orally disintegrating tablets in 2.5-mg and 5-mg formulations. The drug is an FDA-approved generic of Zomig-ZMT, manufactured by AstraZeneca. Zolmitriptan is indicated to treat migraines.

Related Videos
5 experts in this video
5 experts in this video
1 expert is featured in this series.
Happy elderly patient with medical health checkup with cardiologist or geriatric doctor. Senior old aging woman with coronary artery heart disease or cardiac illness check-up in clinic - Image credit: Chinnapong | stock.adobe.com